Krieger E, Qayyum R, Keating A, Toor A, et al. Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML. Bone Marrow Transplant 2021;56:2714-2722.
PMID: 34234295